IMR — Imricor Medical Systems Share News
0.000.00%
Last trade - 00:00- AU$512.72m
- AU$463.18m
- $0.29m
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion
Imricor Medical Systems rises on US FDA clearance for two devices
Brief: Imricor Medical Systems, Inc Submits Third PMA Module To The US FDA For Review
Brief: Imricor Medical Systems Granted ASX Waiver From Listing Rules Effective 26 May
Australia's Imricor Medical Systems slips on discounted placement
Brief: Imricor Medical Systems To Raise A$60 Mln At A$1.85 Per Share
Australia's Imricor rises on seeking FDA nod for product expansion in U.S.
Brief: Imricor Medical Systems Submits Northstar For U.S. Pediatric Expansion
Brief: Imricor Medical Systems Net Loss For Year $25.3 Million
Brief: Imricor Medical Systems Submits Advantage-MR System For FDA 510(K) Clearance
Brief: Imricor Medical Systems Recieves FDA Clearance For Northstar
Brief: Imricor Medical Systems Says FDA Clears Vision-Mr Diagnostic Catheter
Australia's Imricor Medical Systems soars on US FDA clearance for MRI catheter
Brief: Imricor Medical Systems Says IRB Approved UVA Health's Enrolment In Visabl-Afl Clinical Trial
Australia's Imricor Medical Systems jumps on clinical trial progress
Brief: Imricor Medical Systems Completes Human Factors Study For All Devices In FDA Approval Pathway